- Home
- AMD vs NVO Comparison
AMD vs NVO Comparison
Compare AMD & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMD | NVO |
|---|---|---|
| Founded | 1969 | 1923 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.9B | 269.6B |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMD | NVO |
|---|---|---|
| Price | $202.55 | $48.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 35 | 10 |
| Target Price | ★ $255.74 | $54.25 |
| AVG Volume (30 Days) | ★ 34.1M | 20.2M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.50% |
| EPS Growth | ★ 165.00 | N/A |
| EPS | ★ 2.65 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.90 | N/A |
| Revenue Next Year | $39.83 | $4.39 |
| P/E Ratio | $75.20 | ★ $13.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $76.48 | $43.08 |
| 52 Week High | $267.08 | $93.80 |
Technical Indicators
Market Signals| Indicator | AMD | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 39.32 |
| Support Level | $194.83 | $48.08 |
| Resistance Level | $219.65 | $49.85 |
| Average True Range (ATR) | 11.50 | 2.00 |
| MACD | -3.12 | -0.50 |
| Stochastic Oscillator | 19.10 | 31.04 |
Price Performance
Historical ComparisonAbout AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers (including artificial intelligence), industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. However, AMD is emerging as a prominent player in AI GPUs and related hardware. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox.
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.